GM-CSF as Adjuvant Therapy of Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

July 31, 2010

Conditions
Malignant Melanoma
Interventions
DRUG

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

Trial Locations (1)

94109

Northern California Melanoma Center, San Francisco

Sponsors
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Melanoma Research Institute

UNKNOWN

lead

Northern California Melanoma Center

OTHER